- Volume 13 Issue 9
DOI QR Code
Tanshinone II-A Inhibits Angiogenesis through Down Regulation of COX-2 in Human Colorectal Cancer
- Zhou, Li-Hong (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Hu, Qiang (Department of Genernal Surgery, Dahua Hospital) ;
- Sui, Hua (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Ci, Shu-Jun (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Wang, Yan (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Liu, Xuan (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Liu, Ning-Ning (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine) ;
- Yin, Pei-Hao (Department of Genernal Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) ;
- Qin, Jian-Min (Department of Genernal Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) ;
- Li, Qi (Clinic Oncology, Putuo Hospital & Cancer Institute, Shanghai University of Traditional Chinese Medicine)
- Published : 2012.09.30
Angiogenesis plays a significant role in colorectal cancer (CRC) and cyclooxygenase-2 (COX-2) appears to be involved with multiple aspects of CRC angiogenesis. Our aim was to investigate the inhibitory effects of Tan II-A (Tanshinone II-A, Tan II-A) on tumor growth in mice, as well as alteration of expression of COX-2 and VEGF in CRC. We established the mice xenograft model of C26 CRC cell line, and injected 0.5, 1, 2mg/kg of Tan II-A and 1mg/kg of 5-FU in respectively in vivo. Then, we assayed tumor weight and volume, and evaluated microvascular density and expression of VEGF. COX-2 promoter and COX-2 plasmids were transfected into HCT-116 cells, followed by detection of COX-2 promoter activity by chemiluminescence, and detection of COX-2 mRNA expression by fluorescence quantitative PCR. Taken together, the results showed Tan II-A could inhibit tumor growth and suppress the VEGF level in vivo. HCT-116 cell experiments showed marked inhibitory effects of Tan II-A on COX-2 and VEGF in a dose-dependent manner. The results indicate that Tan II-A can effectively inhibit tumor growth and angiogenesis of human colorectal cancer via inhibiting the expression level of COX-2 and VEGF.
- Arentz G, Chataway T, Price TJ, et al (2011). Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels. Clin Proteomics, 8, 16. https://doi.org/10.1186/1559-0275-8-16
- Amini A, Moghaddam SM, Morris DL, et al (2012). The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis. Curr Cancer Drug Targets, 12, 23-43. https://doi.org/10.2174/156800912798888956
- Chen J, Shi DY, Liu SL, et al (2012). Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo. Oncol Rep, 27, 523-8.
- Casimiro S, Luis I, Fernandes A, et al (2012). Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clin Exp Metastasis, 29, 155-64. https://doi.org/10.1007/s10585-011-9438-0
- Chien SY, Kuo SJ, Chen YL, et al (2012). Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Mol Med Report, 5, 282-6.
- Dai ZK, Qin JK, Huang JE, et al (2012). Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells. J Nat Med, 66, 192-201. https://doi.org/10.1007/s11418-011-0576-0
- Dohadwala M, Yang SC, Luo J, et al (2006). Cyclooxygenase-2 dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in nonsmall cell lung cancer. Cancer Res, 66, 5338-45. https://doi.org/10.1158/0008-5472.CAN-05-3635
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Folkman J (1974). Tumor angiogenesis. Adv Cancer Res, 0, 331-58.
- Franchi A, Gallo O, Massi D, et al (2004). Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer, 101, 973-8. https://doi.org/10.1002/cncr.20454
- Itatsu K, Sasaki M, Yamaguchi J, et al (2009). Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factoralpha. Am J Pathol, 174, 829-41. https://doi.org/10.2353/ajpath.2009.080012
- Karahan N, Güney M, Baspinar S, et al (2007). Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaecol Oncol, 28, 184-8.
- Lazar D, Taban S, Ardeleanu C, et al (2008). Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival. Rom J Morphol Embryol, 49, 371-9.
- Tsujii M, Kawano S, Tsuji S, et al (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-16. https://doi.org/10.1016/S0092-8674(00)81433-6
- Wang J, Wang X, Jiang S, et al (2007). Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. J Neurooncol, 82, 11-21. https://doi.org/10.1007/s11060-006-9242-x
- Waldner MJ, Neurath MF (2012). Targeting the VEGF signaling pathway in cancer therapy. Expert Opin Ther Targets, 16, 5-13. https://doi.org/10.1517/14728222.2011.641951
Zhang K, Li J, Meng W, et al (2010).
$C/EBP\beta$and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro. Int J Hematol, 92, 571-8. https://doi.org/10.1007/s12185-010-0686-6
- Zhang Y, Wei RX, Zhu XB, et al (2012). Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro. Anticancer Drugs, 23, 212-9. https://doi.org/10.1097/CAD.0b013e32834e5592
- A Potential Target of Tanshinone IIA for Acute Promyelocytic Leukemia Revealed by Inverse Docking and Drug Repurposing vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4301
- Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6787
- Anticancer Effect of COX-2 Inhibitor DuP-697 Alone and in Combination with Tyrosine Kinase Inhibitor (E7080) on Colon Cancer Cell Lines vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3113
- The Vascular Effects of Sodium Tanshinone IIA Sulphonate in Rodent and Human Pregnancy vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0121897
- Endothelial Cell Proliferation and Vascular Endothelial Growth Factor Expression in Primary Colorectal Cancer and Corresponding Liver Metastases vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4549
- Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer’s disease vol.26, pp.13, 2015, https://doi.org/10.1097/WNR.0000000000000419
- The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells vol.36, pp.1, 2015, https://doi.org/10.3892/ijmm.2015.2195
- Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia vol.308, pp.3, 2015, https://doi.org/10.1152/ajpregu.00222.2014
- Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression vol.12, pp.3, 2016, https://doi.org/10.3892/ol.2016.4860
- Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment vol.28, pp.6, 2018, https://doi.org/10.1097/IGC.0000000000001269
- Salvia mellifera—How Does It Alleviate Chronic Pain? vol.6, pp.1, 2019, https://doi.org/10.3390/medicines6010018